Trending: Bristol Myers Squibb to Buy RayzeBio
27 12월 2023 - 12:28AM
Dow Jones News
0958 ET -- Bristol Myers Squibb is one of the most mentioned
companies in the U.S. across all news items in the last 12 hours,
according to Factiva data. The drugmaker has agreed to buy
radiopharmaceutical therapeutics company RayzeBio for $4.1 billion.
Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
December 26, 2023 10:13 ET (15:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
RayzeBio (NASDAQ:RYZB)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
RayzeBio (NASDAQ:RYZB)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024